Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
In this presentation Sue Ramspacher, Senior Vice President, Portfolio Management, Market Measures/Cozint, summarized results of her firm's 2002 DTC Monitor study.
Online CME: Is the Glass Half-Full or Half-Empty?
More and more physicians are completing CME courses online, according to a survey by Boston Consulting Group. Data from ACCME also show that physician registration for Internet-based CME (enduring materials) also increased. Yet, the percent of physician participants in online CME as a total of all physician participants is very small and
physician use of online CME has not kept pace with their use of the Internet in general.
Online CME – A Glass Half-Full or Half-Empty?
More and more physicians are completing CME courses online, according to a survey by Boston Consulting Group. Data from ACCME also show that physician registration for Internet-based CME (enduring materials) also increased. Yet, the percent of physician participants in online CME as a total of all physician participants is very small and
physician use of online CME has not kept pace with their use of the Internet in general.
CME Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
What strategies should a pharmaceutical company follow to ensure a successful partnership with an academic CME provider? What's an appropriate measure for outcomes (ROI)? What % of income from academeic CME programs comes from pharma support?
Online CME – A Glass Half-Full or Half-Empty?
More and more physicians are completing CME courses online, according to a survey by Boston Consulting Group. Data from ACCME also show that physician registration for Internet-based CME (enduring materials) also increased. Yet, the percent of physician participants in online CME as a total of all physician participants is very small and
physician use of online CME has not kept pace with their use of the Internet in general.
Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
What strategies should a pharmaceutical company follow to ensure a successful partnership with an academic CME provider? What's an appropriate measure for outcomes (ROI)? What % of income from academeic CME programs comes from pharma support?
Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
What strategies should a pharmaceutical company follow to ensure a successful partnership with an academic CME provider? What's an appropriate measure for outcomes (ROI)? What % of income from academeic CME programs comes from pharma support?
ACCME’s Standards for Commercial Support: Understanding What’s at Stake
A joint presentation by John F. Kamp, Ph.D., J.D., Partner, Wiley, Rein & Fielding and Linda Casebeer, Ph.D., Associate Professor, CME at the University of Alabama School of Medicine, offered a point-counterpoint assessment of ACCME's draft Standards for Commercial Support (SCS) and its effect on the partnership between accredited CME providers and pharmaceutical supporters.
Evolving CME Regulation: Responding to the Challenges
Dennis D. Elliott, SVP and Managing Director of S.G. Madison & the CBCE, an accredited CME/CE provider, suggested in this presentation that the recent public scrutiny of pharmaceutical support for CME and the various new guidelines and standards may be having a chilling effect on the business of commercial CME providers.
It’s All About Education
What are the differences between promotion and education? This OpEd piece suggests that promotion should be more educational and education should be more promotional and that CME and other educational materials should be part of the typical drug rep's promotional armamentarium.
